• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cureus . Post-acute Sequelae of SARS-CoV-2 Infection: Do Indians Fare Better?

tetano

Editor, Senior Moderator
Cureus


. 2022 Dec 3;14(12):e32159.
doi: 10.7759/cureus.32159. eCollection 2022 Dec.
Post-acute Sequelae of SARS-CoV-2 Infection: Do Indians Fare Better?


Suja Lakshmanan[SUP] 1 [/SUP], Bhargavi Mv[SUP] 2 [/SUP], Anbukrithiga Dharmalingam[SUP] 2 [/SUP], Emmanuel Bhaskar[SUP] 2 [/SUP], Archa A Anil[SUP] 2 [/SUP], N Senthil[SUP] 3 [/SUP]



Affiliations

Abstract

Introduction: The uplift of SARS-CoV-2 infection has necessitated the understanding of long-term consequences in the affected population. This study was driven by a lack of Indian studies to estimate the torment of post-coronavirus disease 2019 (COVID-19) symptoms and the quality of life.
Methods: This prospective observational study was conducted in a tertiary care centre in South India, between August and November 2020. SARS-CoV-2 hospitalised patients were telephonically questioned regarding the persistence of symptoms along with an assessment of the quality of life using the 15D questionnaire in the first, second, and fourth weeks. Since a majority of the patients had resolution of symptoms by four weeks, the study was not extended for a longer period.
Results: The study included 476 patients whose mean length of hospital stay was 7.67 days. Of the patients, 68.7% had mild severity, 24.8% had moderate disease, and 6.5% had severe disease. About 28.4% required oxygen, 8.2% required ICU care, and 1.3% required mechanical ventilation. Myalgia (13.9%), cough (1.3%), and dyspnoea (6.1%) were the predominant persistent symptoms in the fourth-week post-discharge. All the symptoms of health-related quality of life and physical performance improved by the fourth week, which was statistically significant.
Conclusion: Our study findings are in stark contrast to the studies published from other regions of the world, which show a significant worsening of quality of life even among those with mild illness.

Keywords: covid long haul syndrome; covid-19; persistent symptoms in covid-19; post-covid in indian population; post-covid sequelae; post-covid-19; quality of life; quality of life post-covid.
 
Back
Top Bottom